{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T23:10:15Z","timestamp":1789513815284,"version":"build-2803163510"},"reference-count":59,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Public Health"],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Implementation of lung cancer screening (LCS) has been slow across geographical Europe. Only three countries have a formal LCS program: Croatia, Poland, and England.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This study aims to review the status of LCS and identify the barriers to implementation of formal programs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A framework to assess the status and identify key gaps was used, consisting of five dimensions: (1) policy prioritization and governance, (2) clinical review, (3) program design, (4) implementation, and (5) awareness. The research was conducted in 10 countries including Belgium, Croatia, England, France, Germany, Greece, Italy, Poland, Spain, and Sweden. Across countries, the assessment framework was applied to identify key barriers. The assessment was validated with local experts.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Countries are at different stages of implementation, with large variability in the proposed program design. The cross-country analysis found common barriers. A crucial driver of stimulating political commitment is a local network of well-connected clinicians and patients. Although governments request local data to support decision making, in many countries, local data collection is minimal or stalled. Implementation is the most underdeveloped dimension in the framework, commitment to sufficient funding and infrastructure for scaling up pilots and post screening care delivery is a common barrier. Finally, awareness amongst the public and healthcare professionals requires improvement.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Progress depends on a number of factors namely, political will, funding commitment, a local network of well-connected experts, availability of local evidence, and feasibility assessments.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fpubh.2026.1766560","type":"journal-article","created":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T15:29:38Z","timestamp":1775057378000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["From aspiration to reality: a cross-country analysis of the implementation of lung cancer screening in Europe"],"prefix":"10.3389","volume":"14","author":[{"given":"Charlotte","family":"Poon","sequence":"first","affiliation":[{"name":"Charles River Associates","place":["London, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandra","family":"Martinez Zamora","sequence":"additional","affiliation":[{"name":"Charles River Associates","place":["London, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Wilsdon","sequence":"additional","affiliation":[{"name":"Charles River Associates","place":["London, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Hartevelt","sequence":"additional","affiliation":[{"name":"Merck & Co Inc","place":["Rahway, NJ, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnaud","family":"Papin","sequence":"additional","affiliation":[{"name":"Merck & Co Inc","place":["Rahway, NJ, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,4,1]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1038\/s41571-023-00798-3","article-title":"The global burden of lung cancer: current status and future trends","volume":"20","author":"Leiter","year":"2023","journal-title":"Nat Rev Clin Oncol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1016\/j.healthpol.2022.06.003","article-title":"Should we screen for lung cancer? A 10-country analysis identifying key decision-making factors","volume":"126","author":"Poon","year":"2022","journal-title":"Health Policy."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1264342","DOI":"10.3389\/fpubh.2023.1264342","article-title":"Why is the screening rate in lung cancer still low? A seven-country analysis of the factors affecting adoption","volume":"11","author":"Poon","year":"2023","journal-title":"Front Public Health"},{"key":"B4","unstructured":"Flagship Initiatives - European Commission\n          \n          2024"},{"key":"B5","volume-title":"EU Country Cancer Profile","year":"2023"},{"key":"B6","unstructured":"Lung cancer screening in Poland\n          \n          \n            \n              Arnold\n              H\n            \n          \n          Lung Cancer Policy Netw.\n          \n          2022"},{"key":"B7","unstructured":"New Lung Cancer Screening Roll Out to Detect Cancer Sooner\n          \n          2023"},{"key":"B8","unstructured":"Durchbruch Auf Dem Weg Zu Einem Fr\u00fcherkennungsprogramm F\u00fcr Lungenkrebs | DRG.De\n          \n          2024"},{"key":"B9","doi-asserted-by":"publisher","first-page":"e207","DOI":"10.1016\/S1470-2045(23)00104-3","article-title":"Defining the road map to a UK national lung cancer screening programme","volume":"24","author":"O'Dowd","year":"2023","journal-title":"Lancet Oncol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1093\/tbm\/ibaa121","article-title":"Successes and challenges of implementing a lung cancer screening program in federally qualified health centers: a qualitative analysis using the consolidated framework for implementation research","volume":"11","author":"Allen","year":"2020","journal-title":"Transl Behav Med."},{"key":"B11","unstructured":"Ministerstwo Zdrowia"},{"key":"B12","unstructured":"Bundesumweltministerium l\u00e4sst k\u00fcnftig Lungenkrebsfr\u00fcherkennung mittels Niedrigdosis-Computertomographie zu- BMUV \u2013 Pressemitteilung\n          \n          2024"},{"key":"B13","unstructured":"Se pone en marcha Cassandra, un proyecto piloto de cribado de c\u00e1ncer de pulm\u00f3n. Investigaci\u00f3n\n          \n          2023"},{"key":"B14","unstructured":""},{"key":"B15","unstructured":"Feasibility Study of Lung Cancer Screening in the Flemish Region, the ZORALCS Study\n          \n          2024"},{"key":"B16","unstructured":"D\u00e9pistage du cancer bronchopulmonaire par scanner thoracique faible dose sans injection : actualisation de l'avis de 2016\n          \n          2022"},{"key":"B17","unstructured":"Programme Pilote D\u00e9pistage Des Cancers Du Poumon Pour Fumeurs et Ex-Fumeurs\n          \n          2022"},{"key":"B18","unstructured":"2023"},{"key":"B19","unstructured":"Cribado Del C\u00e1ncer de Pulm\u00f3n Mediante TC de Baja Dosis - Proyecto Piloto Nacional - Documento de Actuacion\n          \n          2022"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.4103\/jfmpc.jfmpc_2406_22","article-title":"Biostatistics behind risk prediction models","volume":"12","author":"Kaushal","year":"2023","journal-title":"J Family Med Prim Care."},{"key":"B21","unstructured":"Risk-Model \u2013 The Roy Castle Lung Cancer Research Program"},{"key":"B22","doi-asserted-by":"publisher","first-page":"e1001787","DOI":"10.1371\/journal.pmed.1001787","article-title":"Correction: evaluation of the lung cancer risks at which to screen ever- and never-smokers: screening rules applied to the PLCO and NLST cohorts","volume":"12","year":"2015","journal-title":"PLoS Med"},{"key":"B23","unstructured":"Standard Protocol Prepared for the Targeted Lung Health Checks Programme\n          \n          2019"},{"key":"B24","unstructured":"The NHS Long Term Plan\n          \n          2019"},{"key":"B25","unstructured":"Croatia National Cancer Control Plan 2020 \u2013 2030\n          \n          2019"},{"key":"B26","unstructured":"MInistero Della Salute - Piano Oncologico Nazionale: Documento Di Pianificazione e Indirizzo per La Prevenzione e Il Contrasto Del Cancro 2023-2027"},{"key":"B27","unstructured":"La Strat\u00e9gie D\u00e9cennale de Lutte Contre Les Cancers 2021-2030 - Strat\u00e9gie de Lutte Contre Les Cancers En France"},{"key":"B28","unstructured":"Breathing a New Era: A Comparative Analysis of Lung Cancer Policies Across Europe"},{"key":"B29","unstructured":"Belgium National Cancer Plan (2008)"},{"key":"B30","volume-title":"EU Country Cancer Profile","year":"2023"},{"key":"B31","unstructured":"2021"},{"key":"B32","unstructured":"Mef Nilbert Leads the Update of a New Swedish Cancer Strategy | LUCC"},{"key":"B33","unstructured":"\u201c\u03a5\u03c0\u03bf\u03c5\u03c1\u03b3\u03b5\u03af\u03bf \u03a5\u03b3\u03b5\u03af\u03b1\u03c2\u201d\n          \n          \n          2023"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1016\/j.jtho.2021.07.022","article-title":"Lung cancer in Belgium","volume":"16","author":"Ocak","year":"2021","journal-title":"J Thorac Oncol."},{"key":"B35","unstructured":"Ministerio de Sanidad - \u00c1reas - Cartera de Servicios Complementaria de Las Comunidades Aut\u00f3nomas y de Las Mutualidades de Funcionarios"},{"key":"B36","unstructured":"Screening \u2013 RCC"},{"key":"B37","volume-title":"EU Country Cancer Profile","year":"2023"},{"key":"B38","unstructured":"Lung Cancer - UK National Screening Committee (UK NSC) - GOV.UK"},{"key":"B39","unstructured":"AEACaP exige soluciones para afrontar el c\u00e1ncer de pulm\u00f3n como la nueva epidemia oculta\n          \n          2023"},{"key":"B40","unstructured":"Workshop Screening Cancro Polmone Razionale\n          \n          2018"},{"key":"B41","unstructured":"Lung Cancer Screening - RCC Knowledge Bank"},{"key":"B42","doi-asserted-by":"publisher","first-page":"S129","DOI":"10.1016\/j.jtho.2024.09.233","article-title":"MA18","volume":"19","author":"Vogel-Claussen","year":"2024","journal-title":"J Thorac Oncol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1055\/a-1853-8291","article-title":"Design and rationale of the HANSE Study: a holistic German lung cancer screening trial using low-dose computed tomography","volume":"194","author":"Vogel-Claussen","year":"2022","journal-title":"R\u00f6Fo - Fortschritte auf dem Gebiet der R\u00f6ntgenstrahlen und der bildgebenden Verfahren."},{"key":"B44","unstructured":"2024"},{"key":"B45","unstructured":"Programme Pilote Du D\u00e9pistage Des Cancers Du Poumon : L'Institut National Du Cancer Publie l'appel \u00e0 Candidatures - Dossiers et Communiqu\u00e9s de Presse\n          \n          2024"},{"key":"B46","unstructured":"Croatia National Cancer Control Plan 2020 \u2013 2030\n          \n          2019"},{"key":"B47","unstructured":"Considerations to Ensure Optimum Roll-Out of Targeted Lung Cancer Screening Over the Next Five Years"},{"key":"B48","unstructured":"Health Funding Data Analysis"},{"key":"B49","unstructured":"Lung Cancer Screening: 2022 Could Be a Turning Point for Europe\n          \n          2022"},{"key":"B50","unstructured":"Lung Check"},{"key":"B51","unstructured":"Tumore al polmone, \u00e8 tempo di pensare a uno screening nazionale. la Repubblica\n          \n          2023"},{"key":"B52","unstructured":"Game Changers IPSOS\n          \n          2020"},{"key":"B53","unstructured":"NHS England, NHS Launches Awareness Campaign for England's Most Deadly Cancer\n          \n          2022"},{"key":"B54","unstructured":"Lung Ambition Alliance"},{"key":"B55","unstructured":"Referentenentwurf einer Verordnung \u00fcber die Zul\u00e4ssigkeit der Anwendung der Niedrigdosis-Computertomographie zur Fr\u00fcherkennung von Lungenkrebs bei Rauchern (Lungenkrebs-Fr\u00fcherkennungs-Verordnung)- BMUV - Gesetze und Verordnungen\n          \n          \n          2024"},{"key":"B56","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1056\/NEJMoa1911793","article-title":"Reduced lung-cancer mortality with volume CT screening in a randomized trial","volume":"382","author":"de Koning","year":"2020","journal-title":"N Engl J Med."},{"key":"B57","unstructured":"Lung Cancer Screening - Current Situation in Sweden - Lung & Allergy Forum"},{"key":"B58","unstructured":"Greece Lung Cancer Screening Medical Societies Recommendations"},{"key":"B59","doi-asserted-by":"publisher","first-page":"e067263","DOI":"10.1136\/bmjopen-2022-067263","article-title":"Lung cancer screening in French women using low-dose CT and artificial intelligence for detection: the CASCADE study protocol","volume":"12","author":"Revel","year":"2022","journal-title":"BMJ Open."}],"container-title":["Frontiers in Public Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2026.1766560\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T15:29:44Z","timestamp":1775057384000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2026.1766560\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,1]]},"references-count":59,"alternative-id":["10.3389\/fpubh.2026.1766560"],"URL":"https:\/\/doi.org\/10.3389\/fpubh.2026.1766560","relation":{},"ISSN":["2296-2565"],"issn-type":[{"value":"2296-2565","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,1]]},"article-number":"1766560"}}